The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.
iShares Core MSCI Intl Dev Mkts ETF IDEV
Morningstar’s Analysis IDEV
Will IDEV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 10.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 1.65 | 251.9 Mil | Healthcare |
ASML Holding NV | 1.44 | 220.6 Mil | Technology |
Nestle SA | 1.14 | 174.0 Mil | Consumer Defensive |
AstraZeneca PLC | 1.03 | 157.6 Mil | Healthcare |
SAP SE | 1.03 | 156.9 Mil | Technology |
Novartis AG Registered Shares | 0.98 | 149.6 Mil | Healthcare |
Roche Holding AG | 0.97 | 147.9 Mil | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 0.92 | 140.5 Mil | Consumer Cyclical |
Shell PLC | 0.88 | 134.5 Mil | Energy |
Toyota Motor Corp | 0.85 | 130.0 Mil | Consumer Cyclical |